Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer

Vaccination against SARS-CoV-2 has been successful in protecting patients with cancer from severe infections, but how immune responses against COVID-19 vaccination interact with those elicited during cancer immunotherapy has not been fully described. Immune checkpoint blockade (ICB) disrupts inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Piening, Alexander, Ebert, Emily, Khojandi, Niloufar, Alspach, Elise, Teague, Ryan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792507/
https://www.ncbi.nlm.nih.gov/pubmed/36582225
http://dx.doi.org/10.3389/fimmu.2022.1022732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792507/
https://www.ncbi.nlm.nih.gov/pubmed/36582225
http://dx.doi.org/10.3389/fimmu.2022.1022732

Ejemplares similares